Mao Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mao Li has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Kun Zhang
Shanghai Normal University
4 shared publicationsZhuoying Liang
Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China
4 shared publications- Carsten Schmuck
Institute for Organic Chemistry, University of Duisburg-Essen, Universitätsstrasse 7, 45141 Essen, Germany
3 shared publications Dejing Liu
Shenzhen Bay Laboratory
3 shared publications- Shirley K. Knauer
Institute for Molecular Biology II, Center of Medical Biotechnology (ZMB), University of Duisburg-Essen, Universitätsstrasse 5, 45141 Essen, Germany
3 shared publications - Alba Gigante
Department of Organic Chemistry University of Duisburg Essen Universitätstr. 7 45141 Essen Germany
2 shared publications
Latest Publications
- 18 November 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
A Tailor-Made Guanidine Ionizable Lipid as a Bifunctional mRNA Carrier and Nitric Oxide Production Inhibitor
Lipid nanoparticles (LNPs) are the leading clinical platform for mRNA delivery, yet their capacity to trigger macrophage-driven inflammatory responses remains a fundamental barrier to therapeutic safety and efficacy. Here, we introduce a design principle in which a tailor-made nitric oxide (NO) inhibitory motif is embedded directly into the ionizable lipid, creating a single molecular scaffold that simultaneously delivers mRNA and suppresses macrophage inflammation. Screening of a focused acyl-guanidine library in LPS-induced peritoneal macrophages identified G9 as a potent NO inhibitor and reprogrammed macrophage polarization from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype. Conjugation of the G9 headgroup to a lipid tail yielded G9-1, an NO-inhibitory ionizable lipid that retains anti-inflammatory activity and preferentially delivers mRNA to pulmonary vascular endothelial cells and alveolar macrophages in vivo. In a murine model of acute lung injury (ALI), G9-1 LNPs loaded with IL-10 mRNA reduce pulmonary immune cell infiltration, suppress inflammatory cytokine production, and attenuate systemic inflammation. These results establish NO inhibition as an actionable molecular design principle for intrinsically anti-inflammatory LNPs and position G9-1 as a dual-function ionizable lipid for safer and more effective mRNA therapeutics.
- 18 November 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
A Tailor-Made Guanidine Ionizable Lipid as a Bifunctional mRNA Carrier and Nitric Oxide Production Inhibitor
Lipid nanoparticles (LNPs) are the leading clinical platform for mRNA delivery, yet their capacity to trigger macrophage-driven inflammatory responses remains a fundamental barrier to therapeutic safety and efficacy. Here, we introduce a design principle in which a tailor-made nitric oxide (NO) inhibitory motif is embedded directly into the ionizable lipid, creating a single molecular scaffold that simultaneously delivers mRNA and suppresses macrophage inflammation. Screening of a focused acyl-guanidine library in LPS-induced peritoneal macrophages identified G9 as a potent NO inhibitor and reprogrammed macrophage polarization from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype. Conjugation of the G9 headgroup to a lipid tail yielded G9-1, an NO-inhibitory ionizable lipid that retains anti-inflammatory activity and preferentially delivers mRNA to pulmonary vascular endothelial cells and alveolar macrophages in vivo. In a murine model of acute lung injury (ALI), G9-1 LNPs loaded with IL-10 mRNA reduce pulmonary immune cell infiltration, suppress inflammatory cytokine production, and attenuate systemic inflammation. These results establish NO inhibition as an actionable molecular design principle for intrinsically anti-inflammatory LNPs and position G9-1 as a dual-function ionizable lipid for safer and more effective mRNA therapeutics.
- Open Access
- 24 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (43) , eadx5970
Ionizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy
The development of lipid nanoparticle (LNP) systems has largely advanced RNA therapeutics, particularly mRNA-based cancer immunotherapy. Conventional amine-LNPs, designed for hepatic RNA delivery, face challenges in targeting lymphoid organs effectively and maximize antigen presentation. In this study, we present the development of pH-responsive ionizable guanidine-LNPs (G-LNPs). Our cholesterol-free G-LNP system enables efficient delivery of mRNA to the spleen following intravenous administration. Notably, while both amine-LNPs and G-LNPs can deliver mRNA to the spleen, G-LNPs exhibit a unique ability to preferentially target antigen-presenting cells, leading to significantly enhanced antigen presentation and robust T cell activation. mRNA vaccines formulated with G-LNPs elicited strong and antigen-specific immune responses, providing complete protection against tumor progression. In addition, intraperitoneal administration of G-LNPs enabled selective mRNA expression in the pancreas, showcasing the versatility of this delivery platform. These findings underscore the potential of guanidine-LNPs as a highly promising platform for organ-targeted mRNA delivery and cancer immunotherapy.
- 24 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (43) , eadx5970
Open AccessIonizable guanidine-based lipid nanoparticle for targeted mRNA delivery and cancer immunotherapy
The development of lipid nanoparticle (LNP) systems has largely advanced RNA therapeutics, particularly mRNA-based cancer immunotherapy. Conventional amine-LNPs, designed for hepatic RNA delivery, face challenges in targeting lymphoid organs effectively and maximize antigen presentation. In this study, we present the development of pH-responsive ionizable guanidine-LNPs (G-LNPs). Our cholesterol-free G-LNP system enables efficient delivery of mRNA to the spleen following intravenous administration. Notably, while both amine-LNPs and G-LNPs can deliver mRNA to the spleen, G-LNPs exhibit a unique ability to preferentially target antigen-presenting cells, leading to significantly enhanced antigen presentation and robust T cell activation. mRNA vaccines formulated with G-LNPs elicited strong and antigen-specific immune responses, providing complete protection against tumor progression. In addition, intraperitoneal administration of G-LNPs enabled selective mRNA expression in the pancreas, showcasing the versatility of this delivery platform. These findings underscore the potential of guanidine-LNPs as a highly promising platform for organ-targeted mRNA delivery and cancer immunotherapy.
Prodrug‐Doped ROS‐Responsive Lipid Nanoparticle for Enhanced mRNA Delivery and Synergistic Anti‐Tumor Therapy
Lipid nanoparticSle (LNP) represents the most advanced mRNA delivery platform for the development of effective cancer therapeutics. Nevertheless, conventional LNP‐mRNA systems are hindered by inadequate endosomal release capability and a lack of synergistic integration with complementary therapeutic approaches. Herein, a reactive oxygen species (ROS)‐responsive prodrug‐doped LNP (LNP‐Pro) that can enhance mRNA delivery efficacy and enable synergistic anti‐tumor therapy is reported. A camptothecin (CPT)‐based prodrug, conjugated to a PEG‐containing block polymer via a ROS‐cleavable linker, is successfully incorporated into clinically approved LNP formulations shown in a report. It shows that LNP‐Pro can respond to the elevated ROS microenvironment in tumor cells, displaying superior delivery capacity in tumor cells relative to normal cells. Furthermore, LNP‐Pro exhibits significantly enhanced mRNA delivery efficacy compared to conventional formulations. In vitro and in vivo studies confirm that LNP‐Pro loaded with therapeutic mRNA synergizes with CPT chemotherapeutic to induce tumor cell apoptosis, achieving significant tumor growth inhibition in a murine model with excellent biocompatibility. Thus, this strategy integrates stimulus‐responsive prodrugs with LNP systems, providing a versatile platform for mRNA‐based cancer therapy.
Prodrug‐Doped ROS‐Responsive Lipid Nanoparticle for Enhanced mRNA Delivery and Synergistic Anti‐Tumor Therapy
Lipid nanoparticSle (LNP) represents the most advanced mRNA delivery platform for the development of effective cancer therapeutics. Nevertheless, conventional LNP‐mRNA systems are hindered by inadequate endosomal release capability and a lack of synergistic integration with complementary therapeutic approaches. Herein, a reactive oxygen species (ROS)‐responsive prodrug‐doped LNP (LNP‐Pro) that can enhance mRNA delivery efficacy and enable synergistic anti‐tumor therapy is reported. A camptothecin (CPT)‐based prodrug, conjugated to a PEG‐containing block polymer via a ROS‐cleavable linker, is successfully incorporated into clinically approved LNP formulations shown in a report. It shows that LNP‐Pro can respond to the elevated ROS microenvironment in tumor cells, displaying superior delivery capacity in tumor cells relative to normal cells. Furthermore, LNP‐Pro exhibits significantly enhanced mRNA delivery efficacy compared to conventional formulations. In vitro and in vivo studies confirm that LNP‐Pro loaded with therapeutic mRNA synergizes with CPT chemotherapeutic to induce tumor cell apoptosis, achieving significant tumor growth inhibition in a murine model with excellent biocompatibility. Thus, this strategy integrates stimulus‐responsive prodrugs with LNP systems, providing a versatile platform for mRNA‐based cancer therapy.
- 15 October 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (43) , 15761-15767
A pH and Light Dual-Responsive Spiropyran-Peptide Self-Assembly for Controlled Mitochondria and Nucleus Targeting
Subcellular targeting represents a highly attractive approach to the development of innovative nanomedicines. Herein, we present a peptide-spiropyran conjugate system that is responsive to both pH and light stimuli. Peptides 1-4 self-assemble in solution and undergo a morphological transition from nanofibers to nanoparticles upon pH or light stimulation. The assembly state exerts a profound influence on their targeting properties: while the nanofiber assemblies predominantly localize to mitochondria, the nanoparticle assemblies enable translocation to the cell nucleus. Furthermore, the gemcitabine conjugate (1-Gem) exhibits potent cytotoxicity against tumor cells, surpassing the efficacy of free gemcitabine by more than 10-fold. 1-Gem is capable of forming coacervates in solution, which can encapsulate additional chemotherapeutic agents. Notably, the combination of 1-Gem and doxorubicin achieves remarkable antitumor activity in the picomolar range. Thus, this work establishes a novel platform for enabling controlled organelle targeting with broad implications for the development of subcellular-targeted therapeutic strategies.
- 15 October 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (43) , 15761-15767
A pH and Light Dual-Responsive Spiropyran-Peptide Self-Assembly for Controlled Mitochondria and Nucleus Targeting
Subcellular targeting represents a highly attractive approach to the development of innovative nanomedicines. Herein, we present a peptide-spiropyran conjugate system that is responsive to both pH and light stimuli. Peptides 1-4 self-assemble in solution and undergo a morphological transition from nanofibers to nanoparticles upon pH or light stimulation. The assembly state exerts a profound influence on their targeting properties: while the nanofiber assemblies predominantly localize to mitochondria, the nanoparticle assemblies enable translocation to the cell nucleus. Furthermore, the gemcitabine conjugate (1-Gem) exhibits potent cytotoxicity against tumor cells, surpassing the efficacy of free gemcitabine by more than 10-fold. 1-Gem is capable of forming coacervates in solution, which can encapsulate additional chemotherapeutic agents. Notably, the combination of 1-Gem and doxorubicin achieves remarkable antitumor activity in the picomolar range. Thus, this work establishes a novel platform for enabling controlled organelle targeting with broad implications for the development of subcellular-targeted therapeutic strategies.
- 26 August 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (18) , e202500391
Direct Cytosolic Uptake of Cell Penetrating Peptides with Shortened Sidechains
Endocytosis and direct translocation serve as the primary mechanisms by which cell‐penetrating peptides (CPPs) enter cells. Understanding these pathways is vital for unraveling the complexities of cellular uptake, which bears significant relevance to progress in various fields. In this study, the intracellular distribution of arginine octamer analogs is demonstrated to correlate with the length of their side chains. Specifically, peptides with elongated sidechains exhibit enhanced cellular uptake efficiency and a preferential endosomal distribution, whereas mR8—a peptide with a shortened sidechain—primarily enters cells via direct translocation and displays cytosolic/nuclear localization. It is further revealed that these structurally analogous peptides exhibit distinct diffusion characteristics and complexation behaviors with model glycosaminoglycans. These findings contribute to a deeper molecular understanding of the cellular uptake mechanisms of peptides.
- 26 August 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (18) , e202500391
Direct Cytosolic Uptake of Cell Penetrating Peptides with Shortened Sidechains
Endocytosis and direct translocation serve as the primary mechanisms by which cell‐penetrating peptides (CPPs) enter cells. Understanding these pathways is vital for unraveling the complexities of cellular uptake, which bears significant relevance to progress in various fields. In this study, the intracellular distribution of arginine octamer analogs is demonstrated to correlate with the length of their side chains. Specifically, peptides with elongated sidechains exhibit enhanced cellular uptake efficiency and a preferential endosomal distribution, whereas mR8—a peptide with a shortened sidechain—primarily enters cells via direct translocation and displays cytosolic/nuclear localization. It is further revealed that these structurally analogous peptides exhibit distinct diffusion characteristics and complexation behaviors with model glycosaminoglycans. These findings contribute to a deeper molecular understanding of the cellular uptake mechanisms of peptides.
- 29 July 2025
- Published by Wiley in Chemistry – A European Journal
- Vol. 31 (46) , e01968
A Light‐Induced Nonequilibrium Peptide Assembly Enables Programmable Catalysis
The dynamic regulation of self‐assembled structures in nonequilibrium states is critical for mimicking biological functions, where energy‐driven processes underpin spatiotemporal control of molecular activities. Herein, we report a light‐responsive peptide assembly system that switches between thermodynamically stable equilibrium nanofibers and energy‐dependent nonequilibrium nanoparticles. This dual‐state behavior is enabled by spiropyran's (SPs) photoisomerization, which switches between the closed‐ring SP and open‐ring merocyanine (MC) forms. Crucially, this morphological transition enables programmable control of catalytic activity in Michael addition reactions. In the dark‐stable equilibrium state, the nanofiber formed by peptide 1 exhibited robust catalysis, achieving over 95% yield. Under blue light, the nonequilibrium nanoparticle assembly of 1 completely abolished catalytic activity. Intermittent light exposure further demonstrates programmable regulation of reaction progression. The system's ability to couple structural dynamics with functional modulation offers a new avenue for designing programmable catalysts and adaptive materials.
- 29 July 2025
- Published by Wiley in Chemistry – A European Journal
- Vol. 31 (46) , e01968
A Light‐Induced Nonequilibrium Peptide Assembly Enables Programmable Catalysis
The dynamic regulation of self‐assembled structures in nonequilibrium states is critical for mimicking biological functions, where energy‐driven processes underpin spatiotemporal control of molecular activities. Herein, we report a light‐responsive peptide assembly system that switches between thermodynamically stable equilibrium nanofibers and energy‐dependent nonequilibrium nanoparticles. This dual‐state behavior is enabled by spiropyran's (SPs) photoisomerization, which switches between the closed‐ring SP and open‐ring merocyanine (MC) forms. Crucially, this morphological transition enables programmable control of catalytic activity in Michael addition reactions. In the dark‐stable equilibrium state, the nanofiber formed by peptide 1 exhibited robust catalysis, achieving over 95% yield. Under blue light, the nonequilibrium nanoparticle assembly of 1 completely abolished catalytic activity. Intermittent light exposure further demonstrates programmable regulation of reaction progression. The system's ability to couple structural dynamics with functional modulation offers a new avenue for designing programmable catalysts and adaptive materials.
- 4 February 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26 (3) , 1595-1603
Acetylation of Short Glycopeptides Enables Phase Separation
Liquid-liquid phase separation (LLPS) of biomacromolecules is crucial for regulating cellular functions. To explore their molecular mechanisms, peptide-based coacervates mimicking natural proteins have been developed, but the role of side chain modifications such as glycosylation remains underexplored. Here, we demonstrate that acetylation of short glycopeptides can induce pH- and concentration-dependent phase separation, while removing acetyl groups abolishes this behavior. Circular dichroism spectroscopy revealed a strong link between peptide structural ordering and the phase separation propensity. Peptides capable of forming liquid droplets displayed a significant ellipticity change at 205 nm upon changing solution pH. Moreover, these peptide coacervates can interact with cells and enhance the antiproliferative property of doxorubicin. Therefore, this work highlights the critical role of O-acetylation in LLPS and provides a valuable tool for studying the parameters regulating LLPS and its implications in cellular processes.
- 4 February 2025
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26 (3) , 1595-1603
Acetylation of Short Glycopeptides Enables Phase Separation
Liquid-liquid phase separation (LLPS) of biomacromolecules is crucial for regulating cellular functions. To explore their molecular mechanisms, peptide-based coacervates mimicking natural proteins have been developed, but the role of side chain modifications such as glycosylation remains underexplored. Here, we demonstrate that acetylation of short glycopeptides can induce pH- and concentration-dependent phase separation, while removing acetyl groups abolishes this behavior. Circular dichroism spectroscopy revealed a strong link between peptide structural ordering and the phase separation propensity. Peptides capable of forming liquid droplets displayed a significant ellipticity change at 205 nm upon changing solution pH. Moreover, these peptide coacervates can interact with cells and enhance the antiproliferative property of doxorubicin. Therefore, this work highlights the critical role of O-acetylation in LLPS and provides a valuable tool for studying the parameters regulating LLPS and its implications in cellular processes.
- Open Access
- 28 August 2024
- Published by Springer Nature in Research Square
Using ionizable guanidine to develop cholesterol-free three-component lipid nanoparticles for spleen-targeted mRNA delivery
Lipid nanoparticle (LNP) represents a key breakthrough in the realm of RNA therapeutics, particularly for the development of mRNA therapeutics and vaccines. Most LNPs developed to date rely on tertiary-amine based ionizable lipids and are mainly limited to liver delivery. Current strategies to alter the targeting performances of LNPs require four or more components, with cholesterol being a crucial element in the formulation. In this study, we introduce a novel approach utilizing an ionizable guanidine analogue, guanidino-carbonyl-pyrrole (GCP), to construct ionizable lipids. These GCP-based lipids can form multilayered, onion-like LNPs. These guanidine-based LNPs are highly sensitive to pH changes in the environment and demonstrate superior mRNA delivery capabilities both in vitro and in vivo. Unlike the commonly used amine-based lipids, GCP-lipids enable the formation of three-component, cholesterol-free LNPs that efficiently deliver functional mRNA to the spleen. Furthermore, we show that the new LNP system could transport mRNA to splenic immune cells with high efficacy, thus providing an exciting opportunity for future applications. Our findings underscore the advantages of ionizable guanidine-based lipids and could pave the way for the development of LNPs capable of targeting tissues beyond the liver.
- 28 August 2024
- Published by Springer Nature in Research Square
Open AccessUsing ionizable guanidine to develop cholesterol-free three-component lipid nanoparticles for spleen-targeted mRNA delivery
Lipid nanoparticle (LNP) represents a key breakthrough in the realm of RNA therapeutics, particularly for the development of mRNA therapeutics and vaccines. Most LNPs developed to date rely on tertiary-amine based ionizable lipids and are mainly limited to liver delivery. Current strategies to alter the targeting performances of LNPs require four or more components, with cholesterol being a crucial element in the formulation. In this study, we introduce a novel approach utilizing an ionizable guanidine analogue, guanidino-carbonyl-pyrrole (GCP), to construct ionizable lipids. These GCP-based lipids can form multilayered, onion-like LNPs. These guanidine-based LNPs are highly sensitive to pH changes in the environment and demonstrate superior mRNA delivery capabilities both in vitro and in vivo. Unlike the commonly used amine-based lipids, GCP-lipids enable the formation of three-component, cholesterol-free LNPs that efficiently deliver functional mRNA to the spleen. Furthermore, we show that the new LNP system could transport mRNA to splenic immune cells with high efficacy, thus providing an exciting opportunity for future applications. Our findings underscore the advantages of ionizable guanidine-based lipids and could pave the way for the development of LNPs capable of targeting tissues beyond the liver.
- 18 June 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (36) , 15586-15589
Delivery of myo ‐Inositol Hexakisphosphate to the Cell Nucleus with a Proline‐Based Cell‐Penetrating Peptide
Inositol hexakisphosphate (InsP 6 ) is a central member of the inositol phosphate messengers in eukaryotic cells. Tools to manipulate the level of InsP 6 , particularly with compartment selectivity, are needed to enable functional cellular studies. We present cationic octa‐(4S)guanidiniumproline ( Z8 ) for the delivery of InsP 6 into the cell nucleus. CD spectroscopy, binding affinity, dynamic light scattering, and computational studies revealed that Z8 binds tightly to InsP 6 and upon binding undergoes a conformational change from a PPII‐helical structure to a structure that forms aggregates. The unique conformational features of the cationic oligoproline enable complex formation and cellular delivery of InsP 6 with considerably greater efficacy than the flexible counterpart octaarginine.
- 18 June 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (36) , 15586-15589
Delivery of myo ‐Inositol Hexakisphosphate to the Cell Nucleus with a Proline‐Based Cell‐Penetrating Peptide
Inositol hexakisphosphate (InsP 6 ) is a central member of the inositol phosphate messengers in eukaryotic cells. Tools to manipulate the level of InsP 6 , particularly with compartment selectivity, are needed to enable functional cellular studies. We present cationic octa‐(4S)guanidiniumproline ( Z8 ) for the delivery of InsP 6 into the cell nucleus. CD spectroscopy, binding affinity, dynamic light scattering, and computational studies revealed that Z8 binds tightly to InsP 6 and upon binding undergoes a conformational change from a PPII‐helical structure to a structure that forms aggregates. The unique conformational features of the cationic oligoproline enable complex formation and cellular delivery of InsP 6 with considerably greater efficacy than the flexible counterpart octaarginine.
- 18 June 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (36) , 15716-15719
Delivery of myo ‐Inositol Hexakisphosphate to the Cell Nucleus with a Proline‐Based Cell‐Penetrating Peptide
Inositol hexakisphosphate (InsP 6 ) is a central member of the inositol phosphate messengers in eukaryotic cells. Tools to manipulate the level of InsP 6 , particularly with compartment selectivity, are needed to enable functional cellular studies. We present cationic octa‐(4S)guanidiniumproline ( Z8 ) for the delivery of InsP 6 into the cell nucleus. CD spectroscopy, binding affinity, dynamic light scattering, and computational studies revealed that Z8 binds tightly to InsP 6 and upon binding undergoes a conformational change from a PPII‐helical structure to a structure that forms aggregates. The unique conformational features of the cationic oligoproline enable complex formation and cellular delivery of InsP 6 with considerably greater efficacy than the flexible counterpart octaarginine.
- 18 June 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (36) , 15716-15719
Delivery of myo ‐Inositol Hexakisphosphate to the Cell Nucleus with a Proline‐Based Cell‐Penetrating Peptide
Inositol hexakisphosphate (InsP 6 ) is a central member of the inositol phosphate messengers in eukaryotic cells. Tools to manipulate the level of InsP 6 , particularly with compartment selectivity, are needed to enable functional cellular studies. We present cationic octa‐(4S)guanidiniumproline ( Z8 ) for the delivery of InsP 6 into the cell nucleus. CD spectroscopy, binding affinity, dynamic light scattering, and computational studies revealed that Z8 binds tightly to InsP 6 and upon binding undergoes a conformational change from a PPII‐helical structure to a structure that forms aggregates. The unique conformational features of the cationic oligoproline enable complex formation and cellular delivery of InsP 6 with considerably greater efficacy than the flexible counterpart octaarginine.